📰 Genentech News
Page 171 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
April 25, 2023
Post-hoc analyses from four phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in neovascular or ‘wet’ age-related macular degeneration and diabetic... | April 25, 2023
April 25, 2023
‒ Post-hoc analyses from four Phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in wet age-related macular degeneration and diabetic macular edema ... | April 25, 2023
April 25, 2023
Robert Califf expressed concern that the U.S. ranks almost last among high-income countries for health outcomes.
April 25, 2023
A drug tested on patients with nonproliferative diabetic retinopathy did not improve vision outcomes.
April 25, 2023
Post-hoc analyses from four Phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in wet age-related macular degeneration (AMD) and diabetic macular edema (DME) - More
April 25, 2023
25.04.2023 - BOSTON, April 25, 2023 (GLOBE NEWSWIRE) - Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within ... Seite 1
April 25, 2023
Discovery Education Celebrates DNA Education on DNA Day With Curated ...
April 25, 2023
Treatment with teriflunomide resulted in a 63% risk reduction relative to placebo in preventing the first symptoms of multiple sclerosis in individuals with radiologically isolated syndrome.
April 24, 2023
/PRNewswire/ -- CPower Energy ("CPower"), the national leader in unlocking the value of customer Distributed Energy Resources (DERs), has received a 2023...
April 24, 2023
–– Roche, Genentech and partners embark on global prevalence research, trend-spotting with digital analysis, and telehealth initiatives to assess & address deterrents to brain health... | June 18, 2023